Company Profile

Addex Therapeutics (NASDAQ: ADXN)
8:30 PM UTC, 07/02/24
Last: $7.84 Change: +0.00 %Change: +0.06% Volume: 3,472
Detailed Quote
Open: $ 7.97   Volume: 3,472
High: $ 8.29   Yield(%) 0.00
Low: $ 7.84   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 6.42M
EPS ($) -17.95   Shares Out: 819,222.95
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -12.11
% Price Change (last 13 weeks): -40.79
% Price Change (last 26 weeks): 24.48
% Price Change (last 52 weeks): -32.47
% Price Change (year to date): 29.59
Management Effectiveness
Return on Equity (%): -352.40
Return on Assets (%): -162.44
Return on Invested Capital (%): -145.22
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -652.75
Operating Profit Margin (%): -637.60
Price & Volume
50-day Moving Average: $9.27
200-day Moving Average: $9.19
Avg. Daily Vol. (last 50 days): 10,087
Avg. Daily Vol. (last 200 days): 11,787
52-wk high: $27.90
52-wk low: $5.00
Bid: $3.14
Ask: $9.89
Company Information
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Addex Therapeutics
9, Chemin des Mines Plan-les-Ouates
Geneva GE 1202

Phone: 41.22.884.15.55
Fax: 41.22.884.15.56
http://www.addextherapeutics.com
Per Share Data
Earnings (1year) ($): -17.95
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 1.71
Cash Flow ($): -14.37
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 2.08
Price/Book (x): 3.53
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.46
Current Ratio (x): 1.46
LT Debt/Equity (x): 6.15
Total Debt/Equity (x): 30.08



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.